Hagop Kantarjian

MD Anderson Cancer Center

Guest

Chair of the Department of Leukemia at the University of Texas' MD Anderson Cancer Center in Houston

Hagop Kantarjian on KCRW

One third of all Americans will get some form of cancer during their lifetimes — and the average cost of drug treatment is $100,000 a year.

The Rising Cost of Fighting Cancer

One third of all Americans will get some form of cancer during their lifetimes — and the average cost of drug treatment is $100,000 a year.

from To the Point

More from KCRW

At a rally in Beverly Hills, local Ukrainians and their supporters gathered to voice opposition to President Trump’s politics regarding Russia and Ukraine.

from KCRW Features

Israel’s cabinet approved plans that include “conquering the [Gaza] strip,” which would displace over a million Gazans. It could lead to long-term Israeli occupation of the territory.

from Press Play with Madeleine Brand

Trump’s tariffs could cause problems for Southern California’s logistics industry, from the ports to trucking and warehouses.

from KCRW Features

In his first speech from the balcony of St. Peter’s Basilica, Pope Leo XIV – a 69-year-old Chicago native – shared a message of peace. He is the first American pope.

from Press Play with Madeleine Brand

The right says it’s pushing back on cancel culture. Are they just redefining it? Plus, the president banishes pennies and paper straws.

from Left, Right & Center

The U.S. Department of Education has announced that the collection of past-due student loans will resume on May 5. How will this affect your financial reality?

from KCRW Features

Were the April special elections a win for Democrats? How will Trump’s “Liberation Day” tariffs affect American consumers? Plus, KCRW discusses the feasibility of a third Trump term.

from Left, Right & Center

Donald Trump points fingers at Volodymyr Zelensky about the war with Russia. Should the president take accountability for the DOJ? Plus, how valuable are political rallies?

from Left, Right & Center

KCRW unravels a disruptive White House week. Is the president just stirring outrage? Plus, we discuss Elon Musk’s influence on the foreign aid fight.

from Left, Right & Center